We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal IBA  Group

Download Mobile App




Breast Cancer Tumors Grow Faster in Younger Women

By HospiMedica staff writers
Posted on 20 May 2008
A new study shows that tumor growth rates vary considerably among patients, with generally slower growth rates with increasing age at diagnosis. More...


Researchers at the Cancer Registry of Norway (Oslo) developed a likelihood based estimating procedure, where both tumor growth and screen test sensitivity (STS) were modeled as continuously increasing functions of tumor size. The estimating procedure to follow tumor growth was based on breast screening results from 395,188 women aged between 50 and 69 years old included in the Norwegian breast cancer screening program.

The researchers found that tumor growth varied considerably between subjects, with 5% of tumors needing less than 1.2 months to grow from 10 to 20 mm in diameter, and another 5% using more than 6.3 years. The mean time a tumor needed to grow from 10 to 20 mm in diameter was estimated at1.7 years, increasing with age. STS was estimated to increase sharply with tumor size, going from 26 % at 5 mm to 91 % at 10 mm. Compared to previously used Markov models for tumor progression, the applied model gave considerably higher model fit (85 % increased predictive power) and provided estimates directly linked to tumor size. The study was published online on May 8, 2008, in Breast Cancer Research, a publication of BioMed Central (www.biomedcentral.com).

"There are enormous implications for the sensitivity of breast cancer screening programs,” said Harald Weedon-Fekjær, a statistician the department of etiological research. "We found that mammography screen test sensitivity (STS) increases sharply with increased tumor size, as one might expect. Detection rates are just 26% for a 5 mm tumor but increase to 91% once a tumor is 10 mm in size.”

The study also describes a new model for estimating the proportion of breast cancers, which are detected at screening, and the ability of mammography screening to detect tumors.


Related Links:
Cancer Registry of Norway
BioMed Central

Platinum Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Gold Member
Electrode Solution and Skin Prep
Signaspray
Critical Care Conversion Kit
Adapter+
Infant Incubator
OKM 801
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.